Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | ADH1B | P00325 | 2/20 | 0.34 |
| ▸ | ADH1C | P00326 | 2/20 | 0.34 |
| ▸ | ADH1A | P07327 | 2/20 | 0.34 |
| ▸ | ADH7 | P40394 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | ADH4 | P08319 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27797457 | 0.93 | DNM1 (0.41) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL16061313 | 0.91 | DNM1 (0.44) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL7675879 | 0.86 | — | — | |
| SCHEMBL11498364 | 0.84 | TSHR (0.40) | TSHRSMN1; SMN2ATMADH1BADH1C | |
| SCHEMBL8995773 | 0.83 | CYP3A4 (0.37) | TSHRSMN1; SMN2ATMADH1BADH1C | |
| SCHEMBL18506725 | 0.83 | ALDH1A1 (0.40) | TSHRSMN1; SMN2ATMADH1BADH1C | |
| SCHEMBL10432238 | 0.83 | TSHR (0.35) | TSHRSMN1; SMN2ATMADH1BADH1C | |
| SCHEMBL18506731 | 0.83 | ALDH1A1 (0.40) | TSHRSMN1; SMN2ATMADH1BADH1C | |
| SCHEMBL16562014 | 0.81 | LPAR1 (0.40) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL13354395 | 0.81 | ADH1B (0.41) | TSHRSMN1; SMN2ADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| CN-114591232-A | Long-acting control agent for ectoparasites of animals | 三井化学AGRO株式会社 | 2022-06-07 | — | — | CN | disclosed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | disclosed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | disclosed |
| EP-0308411-A1 | PROCESS FOR HYDROGENATING AN UNSATURATED ORGANIC COMPOUND | DAVY McKEE (LONDON) LIMITED (GB) | 1989-03-29 | — | — | EP | disclosed |
| EP-0300018-A1 | HYDROGENATION PROCESS. | DAVY MCKEE LONDON (GB) | 1989-01-25 | — | — | EP | disclosed |
| WO-1988005767-A1 | HYDROGENATION PROCESS | DAVY MCKEE (LONDON) LIMITED (GB) | 1988-08-11 | — | — | WO | disclosed |
| EP-0277168-A1 | PROCESS FOR THE CO-PRODUCTION OF BUTANE-1,4-DIOL AND $i(GAMMA)-BUTYROLACTONE | DAVY McKEE (LONDON) LIMITED (GB) | 1988-08-10 | — | — | EP | disclosed |
| WO-1988000937-A1 | PROCESS FOR THE CO-PRODUCTION OF BUTANE-1,4-DIOL AND GAMMA-BUTYROLACTONE | DAVY MCKEE (LONDON) LIMITED (GB) | 1988-02-11 | — | — | WO | disclosed |
| WO-1987007598-A1 | PROCESS FOR HYDROGENATING AN UNSATURATED ORGANIC COMPOUND | DAVY MCKEE (LONDON) LIMITED (GB) | 1987-12-17 | — | — | WO | disclosed |
| EP-0223814-A1 | PROCESS FOR THE PRODUCTION OF $i(GAMMA)-BUTYROLACTONE | DAVY McKEE (LONDON) LIMITED (GB) | 1987-06-03 | — | — | EP | disclosed |
| WO-1986007358-A1 | PROCESS FOR THE PRODUCTION OF GAMMA-BUTYROLACTONE | DAVY MCKEE (LONDON) LIMITED (GB) | 1986-12-18 | — | — | WO | disclosed |
| EP-0204730-A1 | PROCESS FOR THE PRODUCTION OF BUTANE-1,4-DIOL | DAVY McKEE (LONDON) LIMITED (GB) | 1986-12-17 | — | — | EP | disclosed |
| WO-1986003189-A1 | PROCESS FOR THE PRODUCTION OF BUTANE-1,4-DIOL | DAVY MCKEE (LONDON) LIMITED (GB) | 1986-06-05 | — | — | WO | disclosed |
| EP-0024532-A1 | Tert. butoxybutanales and butanoles and bis-tert. butoxy-pentanales and pentanoles, their production and their use as perfumes | BASF Aktiengesellschaft (DE) | 1981-03-11 | — | — | EP | disclosed |